ENOV:NYSE
Enovis Corp
$19.98
arrow_upward
+7.65%(+1.42) 1D
$20.00
arrow_upward
+0.10% (+0.020)bedtimeAfter hours
Closed: Sep 8, 4:00:06 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ENOV...
Open
$19.15
High
$20.22
Low
$18.57
Mkt. cap
1.15B
Avg. vol.
1.28M
Volume
3.74M
52-wk high
$34.28
52-wk low
$18.52
EPS
-$19.27
Beta
1.10
Shares outstanding
57.67M
No. of employees
8K
Open
$19.15
High
$20.22
Low
$18.57
Mkt. cap
1.15B
Avg. vol.
1.28M
Volume
3.74M
52-wk high
$34.28
52-wk low
$18.52
EPS
-$19.27
Beta
1.10
Shares outstanding
57.67M
No. of employees
8K
News stories
From web sources and news partners
Investing.com
·
6 minutes ago
Enovis CAO Oliver Engert buys $50,008 in company stock
Stock Titan
·
1 hour ago
Enovis CORP (ENOV) insider adds 2,660 shares in open-market buy
Kalkine Media
·
7 hours ago
Enovis CORP CEO McDonald Damien Acquires 13,035 Shares at $19.15 on September 4, 2026
Profile
Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Dallas, Texas and is listed on the NYSE as ENOV. The company has over 8,000 employees operating at 30 sites around the world. Wikipedia
About Enovis Corp
CEOMatthew L. Trerotola
Employees7.8K
Founded1995
HeadquartersWilmington, Delaware, United States
SectorMedical device
Websiteenovis.com